Monday December 30, 2002 • THE NEW FRONTIER OF BIOMEDICINE: 2003 is the year in which proteomics starts taking over the frontiers of biomedicine - San Diego Tribune • Tegal Sells 900 Series Etch System for Biochip Fabrication to Zyomyx: January Installation Scheduled for U.S.-Based Proteomics Analysis Leader • Celebrex, a COX-2 inhibitor, Fails to Lower Risk of New Ulcers • PNNL Researchers Find New Proteins in Blood
Sunday December 22, 2002 • Kinexus Study Reveals Unexpected Changes in Protein Kinase Profiles • Proteome Sciences Collaboration and Licensing Deal with Biosite for Stroke Research • LSBC and Growers Research Group Sign New Funded Research Contract • Lynx Announces Initiation of Gene Expression Analysis Services For Woods Hole Oceanographic Institution • Lynx to Appeal Nasdaq Notice of Delisting • ACT and CREM Proteins Essential to Making Healthy Sperm • AIDS virus protein, gp120, eludes body's defenses, study in Nature finds • Pain Isn't the Same Between the Sexes due to GIRKS proteins • Eye Protein, melanopsin, a Key Regulator of Body Clock • Invitrogen Believed Close to Acquiring Panvera • AxCell's Becker Tapped to Run Cytogen as CEO Steps Down; AxCell Remains on Course • BD Biosciences Licenses Proteomics Technology from Stanford • Caliper Agrees to Reduced Sales Schedule from Amphora • Huge Magnets Come to Harlem: New York Structural Biology Center Launches Protein Powerhouse in Manhattan
Sunday December 15, 2002 • Blood Journal Article by LSBC Scientist Demonstrates that Bone Marrow Stem Cells Can Be Expanded Quantitatively In Vitro • Scientists Shed New Light on the Body's Internal Clock • Waters cuts 4th-quarter outlook as orders weaken • Applied Biosystems Shares Slip After Rival's Warning • Biotech Endures: Looking Back at 2002 and Ahead to 2003 ... • Ciphergen Opens Biomarker Discovery Center in Japan • Matritech Announces $1.18 Million Financing • Kinexus Study Reveals Unexpected Changes in Protein Kinase Profiles • Gradipore Introduces Breakthrough New MicroGel™ Precast Gradient Gel Line For High-Throughput Proteomics Research • IBC Announces 2 Premier Events, Proteomics and Protein Microarrays, Combine to Form 1 Must Attend Event! • Scimagix and Roche Enter Collaboration to Advance Proteomics Research • Delta Search Labs & Proteome Systems to Explore the Intersection of Computational Engineering & Proteomics • Purely Proteins Limited Announces Bioinformatics and Pharmacology Database Licence Agreement with Cytomyx Limited • LaunchCyte Signs Exclusive Option with Carnegie Mellon for Breakthrough Protein-Isolation Technology: ProteoPure • Proteome Systems and Nestle Announce Research Collaboration on the Glycoproteomics of Milk • Lynx and Molecular Engines Laboratories Announce Publication of Results from Gene Expression Analyses in Biological Models of Tumor Reversion • Protiveris Develops Innovative Laser Technology: Vertical Cavity Surface Emitting Laser Critical to the Development Of Microfluidic Protein Biochip System • SYN X Pharma and the U of Ottawa Heart Institute Sign License Agreement to Develop and Commercialize Heart Institute Patents • Structural Genomix and Hereditary Disease Foundation Explore Huntington's Disease Protein
Sunday December 8, 2002 • Illumina Notifies AB of Breach of Joint Development Agreement • LSBC to Present Clinical Data for Plant-Derived Lymphoma Vaccines, Stem Cell Breakthroughs and Three Additional Scientific Advances at American Society of Hematology Conference • Genome Prairie appoints CSO • Structural Bioinformatics Recruits Dr. J. Edward Semple as Executive Director of Medicinal Chemistry • Protiveris Appoints New Management Team • Gyros AB Continues Expansion, Opens German Sales Office • UW to Spend $9M on Proteomics, Bioinformatics, and Gene Expression for Liver-Disease Study • Proteomics Battens Down the Hatches • MIT Proteomics Guru, Peter Kim, to Lead Merck • Harvard Bioscience awarded Hybridization Patent
Sunday December 1, 2002 • HTS Biosystems & Applied Biosystems to Present Research on Next-Generation Protein Affinity Array Technology at IBC's Annual International Conference on Antibody Engineering • Lynx Seeks Approval For Reverse Stock Split • Spinal Fluid Proteins May Help ID Alzheimer's Risk • Protein Predicts Heart Risk Better Than Cholesterol • Protein May Predict Breast Cancer Prognosis: Study
Monday November 25, 2002 • Technologene: The Proteome Solution Leads the Way in Proteomics With Patent for Protein Manufacturing • Amersham Biosciences Is Exclusive Provider of SurModics Slides • ActivX Announces Kyorin Pharmaceutical Makes Equity Investment in Company • Molecular Mining Corp Announces the Release of GeneLinker Gold Version 3.0 & GeneLinker Platinum Version 2.0 • SYN X Pharma Introduces Unique Test for Congestive Heart Failure with Increased Predictive Power • Scimagix Expands European Presence, Bolsters Executive Team • HTS Biosystems and Ciencia Awarded Phase II Grant from NASA: Proprietary Sensing Instrumentation to Advance Study of Proteins in Space Biology • Syrrx Researchers Report Structures of Multiple Cancer-Related Proteins Determined Using Proprietary Nanovolume Crystallization Technology
Friday November 15, 2002 • Lynx Announces Its Financial Results for the Q3 of 2002 • Evotec Reports Solid Performance in Q3 2002 • TissueInformatics Launches Industry's First TissueAnalytics Laboratory for Automated Quantitative Analysis of Tissue • Structural Bioinformatics Announces New Version of StructureBank • SYN X Pharma Executes Distribution Agreement with Princeton BioMeditech Ahead of Schedule - First Sale of Product Exceeds Expectations • Incyte Announces $88 Million Expense Reduction, Launch of Its First Drug Discovery Program and Q3 2002 Financial Results • GPC Biotech Reports Successful Course of Business for the First Nine Months of 2002 • Lynx Announces Successful Completion of Initial MPSS™ Analyses for The Ludwig Institute for Cancer Research • Advion BioSciences Adds VP of Sales and Marketing • Myriad CEO Peter Meldrum Named a Top 50 Scientific Visionary • Luminex Announces Execution of Three Multi-Year Agreements With Bayer Diagnostics • Protein Structure Consortium Wins $6.5 Million from NIH • Big Plans for Little Correlogic: Catch Cancer with Protein Pattern Tests
Friday November 8, 2002 • Proteomics Revolution at Versailles: Global Congress November 21-24 • Compugen Announces Licensing of its Z4000 System for Proteomic Research to Organon and Procter & Gamble • NeoGenomics Signs Research Collaboration Agreement With Ciphergen • Advion BioSciences Adds VP of Sales and Marketing - Company to Ramp Up Commercialization of Its NanoMate Products • Agilix Announces New GenCompass Whole Genome Analysis Microarray Technology • Molecular Staging Awarded SBIR Grant To Develop a Biomarker Chip for Enhanced Diagnosis of Osteoarthritis • Bio-Rad Reports Q3 Results • Biacore Awarded Distinctions In Drug Discovery Technology and Product Innovation • Correlogic Systems Licenses Ovarian Cancer Diagnostic Test to Quest Diagnostics and LabCorp • Structural Bioinformatics Recruits GlaxoSmithKline Executive as European Managing Director • Ciphergen Announces Expanded Use of its SELDI ProteinChip® Technology And Biomarker Discovery Center® Compound Profiling Services with Novartis • Cytogen Reports 32 Percent Increase in Marketed Product Sales for Third Quarter 2002 • Technology Solutions for the Life Sciences Take Center Stage At BioITWorld Conference & EXPO • OGS Announces the Start of a Phase I Clinical Study with OGT 923 • Myriad Reports Results for Q1 of Fiscal 2003 • In Silico Biology Set to Revolutionize the Drug Discovery Process
Friday November 1, 2002 • Chips to Hits a 'Hit' with the Audience; Overwhelming Response to the Show Made it a Sell Out for the Third Straight Year • Progenics Awarded $1 Million From NIH for Development of Novel Prostate Cancer Immunotherapies • Structural Bioinformatics Develops Novel Compound for Sickle Cell Disease • Serenex Signs Drug Discovery Agreement: Proteome Mining Technology to Enhance Drug Research and Development Strategies • Myriad and Genetic Technologies Announce Strategic Licensing Agreement • ACLARA Introduces eTag™ Assay System for Multiplexed Gene And Protein Expression • MolecularWare Releases Version 2.5 of DigitalGenome Software • The National Center for Genome Resources Releases Version 2.0 Of PathDB™ • GeneData Positions PathoLead as the First Bioinformatics Solution For Infectious Disease Research • Ciphergen Achieves ISO 9001 Management System Certification • Ciphergen Reports Q3 2002 Financial Results;Revenues Increased 90% • Matritech Reports Q3 Financial Results; Revenue up 53 percent for the quarter- -Richard Sandberg elected CFO • Agilix Announces New GenCompass Whole Genome Analysis Microarray Technology • Caliper Posts Flat Revenues, Widened Net Loss in Q3 • Prolinx Trims Staff by Half, Suspends Some Marketing to Save for Acapella Launch • PerkinElmer to Combine Analytical Instruments, Life Sciences Units
Friday October 25, 2002 • HBIO Expects Completion of the Acquisition of Genomic Solutions • Bio-Rad Breaking Ground in Life Science Business • Cytogen Board of Directors Authorizes 1 for 10 Reverse Stock Split • Gyros AB Expands European Operations • LSBC Reports Financial Results for Q3 2002 • Lynx Invites You to Participate in Its Q3 2002 Conference Call • Biacore: Interim Report January - September 2002 • Illumina Reports Financial Results for Q3 2002 • CuraGen Reports Q3 2002 Financial Results • Celera Genomics Reports Q1 Fiscal 2003 Results • Bruker Daltonics To Webcast Q3 Conference Call On November 4, 2002 • Luminex Reports 2002 Q3 Results • Ciphergen Announces Revised Q3 2002 Earnings Release Date
Friday October 18, 2002 • Ciphergen Introduces New Automated ProteinChip® Biomarker System • Ciphergen Announces Q3 2002 Earnings and Web Cast Conference Call Details • Structural Bioinformatics Announces US Patent for Novel Anthrax Lethal Factor Inhibitors • SYN X Pharma Signs Letter of Intent to Distribute Princeton BioMeditech's Point-of-Care Diagnostic Products in Canada • Applied Biosystems and Celera Genomics Q1 FY 2003 Financial Results and Conference Call Scheduled For October 24, 2002 • GeneData Enters Into Licensing Agreement with Wyeth To Use Phylosopher(TM) System • Protein Patterns in Blood May Predict Prostate Cancer Diagnosis • ARIUS and Xerion Launch Colon Cancer Collaboration: Joint collaboration will validate ARIUS antibody treatments and identify antigens using Xerion's proprietary functional proteomics technology • Cytogen To Be Featured At The Wall Street Transcript & Wall Street Webcasting's Undiscovered Stocks Conference • Christine Arakelian Joins LSBC Business Development • Thermo Electron and Partners HealthCare Launch Research Collaboration: Celebrate the Opening of the Proteomics Facility at the Harvard-Partners Center for Genetics and Genomics with Proteomics Symposium
Monday October 14, 2002 • Agilent Technologies to License LSBC's Proteomics Sample Preparation Technology • Structural Bioinformatics and AtheroGenics Announce Drug Discovery Collaboration • Waters to Purchase Rheometric Scientific's Rheology Business • Matritech Signs First Partnership to Provide Blood Test for Breast Cancer • Nobel Prize Awarded to Syrrx Scientific Advisory Board Member, Kurt Wuthrich, Ph.D. • Beyond Genomics Plays Major Role in NIH Contract Awarded to BU School of Medicine: Proteomics Technologies Key to $12 Million Award • SYN X Pharma Enters into Exclusive Licensing Agreement for Alzheimer's Disease Technology • Luminex Q3 2002 Earnings Release Scheduled for October 24, 2002 • Agilent Technologies Obtains License for Millennium's SpectrumMill Software: Companies Also to Collaborate on Proteomics Technology • Incyte Authorizes Stock Repurchase Program
Wednesday October 9, 2002 • Institute for Systems Biology Awarded $19.8 Million Contract and Named Center for Major Proteomics Initiative • New D&MD Briefing -- Proteomics and Bioethics: The Future of the Human Genome • 20/20 GeneSystems Enters Technology Access Agreement With Novartis: Proteomics Platform to Help Oncology Unit Survey Tumors • Nobel Prize Awarded to Dr. Sydney Brenner, Lynx's Principal Scientific Advisor • LSBC Receives $2 Million NIST ATP Award to Develop Next-Generation Vaccine Technology • GeneData Completes First Year of Development Partnership With Altana Pharma in HTS Data Analysis • Prolinx Announces Distribution Agreement with VWR for RapXtract Superparamagnetic Separation Technology • Aspira Biosystems Announces Issuance of Key Patent Covering the Company's Core Intellectual Property • Bruker Daltonics Reports Strong Third Quarter 2002 Bookings Growth • Former AstraZeneca R&D Head Appointed New Chairman of Gyros AB • Thermo Set for Two New Proteomics Releases in Õ03 as Restructuring Inches Along • National Heart, Lung, and Blood Institute Pledges $157M for 10-Center Proteomics Initiative • Xerion raises Euro 12.3 Million in a Third Round of Financing to Progress Pre-Clinical Development of Antibody Pipeline • NextGen Sciences receives UK Government SMART award to develop new proteomics technologies for protein discovery applications
Friday October 4, 2002 • OGS Interim Results For The Six Months Ending 30 June 2002 • Genome Technology Names the 2002 GT All-Stars • Beckman Coulter Puts New Spin on Critical Research and Development Tool Launches New Advanced Ultracentrifuge System for Protein and Cellular Research • Accelrys Introduces First Discovery Studio BioInformatics Data Management Solution: DS SeqStore
Wednesday October 2, 2002 • Charles River Laboratories and Proteome Systems Launch Joint Venture in Proteomics Services • Molecular Mining Corporation to Exhibit at GSAC and Human Genetics Conferences • NeoTherapeutics and GPC Biotech Sign Agreement To Co-Develop Phase 3 Oral Anti-Cancer Drug • Amersham' AKTA 3D Kit Yields Highly Pure Protein in Large Quantities • Indiana Proteomics Consortium Names Vice-President, Business Development • Amersham' Innovative ECL Advance Kit Offers 10-Fold Increased Sensitivity in Protein Detection • EraGen' Nucleic Acid Technology Validated by FDA Approval of Bayer Diagnostics' VERSANT® HIV-1 RNA 3.0 Assay • Ventria Announces the Launch of ExpressTec™, a Protein Technology Breakthrough for Plant Made Pharmaceuticals • SurroMed Announces Agreement with PPD Discovery for Cell Surface Target Validation: Agreement to Focus on Comparative Proteomic and Metabolomic Analysis of Tumor Samples
Copyright © 2004 ProteinScience.com. All rights reserved. ProteinScience.com is not affiliated with Protein Sciences, Inc. or the journal Protein Science.
